Literature DB >> 8943675

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

E Salminen1, J M Nuutinen, S Huhtala.   

Abstract

The aim of this study was to evaluate the outcome and prognostic factors influencing survival in 106 patients with supratentorial malignant gliomas treated with radiotherapy. The study group included 84 patients treated by surgery and post-operative radiotherapy and 22 patients treated by postbiopsy irradiation. Radiotherapy was delivered to the tumour area with a 2 cm margin, the aimed curative dose was 60 Gy in 6-7 weeks. The 60-month overall survival (Kaplan-Meier) was 20%. Following a univariate analysis, younger age (P < 0.001), longer duration of symptoms (P = 0.009), good performance status after radiotherapy (P < 0.001), other than grade 4 histology (P < 0.001) and higher radiation dose (P < 0.001) were associated with better overall survival rates. Multivariate analysis found that age, symptom duration, histology, extent of symptoms and radiation dose were independent prognostic factors influencing survival. In conclusion, conventional radiotherapy of supratentorial malignant gliomas results in survival that is comparable to results from clinical experiments with different fractionation schedules and radiation with chemotherapy or radiosensitisers. To improve the results, new approaches are needed, especially for patients with the poorest prognosis after standard treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8943675     DOI: 10.1016/0959-8049(96)00211-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?

Authors:  R D Oehring; M Miletic; M M Valter; T Pietsch; J Neumann; R Fimmers; U Schlegel
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

2.  Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.

Authors:  K L Chow; Y P Gobin; T Cloughesy; J W Sayre; J P Villablanca; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

3.  Conditional survival of high-grade glioma in Los Angeles County during the year 1990-2000.

Authors:  Denice D Tsao-Wei; Jia Hu; Susan G Groshen; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2012-08-09       Impact factor: 4.130

4.  Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

Authors:  R Kirla; E Salminen; S Huhtala; J Nuutinen; L Talve; H Haapasalo; H Kalimo
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.

Authors:  J Shinoda; N Sakai; S Murase; H Yano; T Matsuhisa; T Funakoshi
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

6.  Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Authors:  Birthe Krogh Rasmussen; Steinbjørn Hansen; René J Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2017-08-31       Impact factor: 4.130

7.  Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

Authors:  C Goetz; P Riva; G Poepperl; F J Gildehaus; A Hischa; K Tatsch; H J Reulen
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

8.  Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Takuhito Narita; Shigeru Yamaguchi; Hiroyuki Kobayashi; Mishie Tanino; Taichi Kimura; Shunsuke Terasaka; Shinya Tanaka
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

9.  Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018.

Authors:  Mirketa Marku; Birthe Krogh Rasmussen; Federica Belmonte; Steinbjørn Hansen; Elisabeth Anne Wreford Andersen; Christoffer Johansen; Pernille Envold Bidstrup
Journal:  J Neurol       Date:  2021-06-24       Impact factor: 6.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.